{"id":69072,"name":"OCTAPHARMA USA, INC.","slug":"octapharma-usa-inc","state":"NJ","country":"United States of America","description":"Pharmaceuticals","totalSpending":140000,"filings":3,"yearlySpending":[{"year":2025,"income":140000}],"issues":[{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"MAN","display":"Manufacturing"},{"code":"DEF","display":"Defense"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["CORNERSTONE GOVERNMENT AFFAIRS, INC."],"lobbyists":["RONALD STORHAUG","DABNEY HEGG","CHRISTOPHER HODGSON","ANTHONY LAZARSKI","SUSAN SWEAT","WENDY SAMMONS-JACKSON","JONATHAN MILLER","MARK HARMON"],"govEntities":["Defense, Dept of (DOD)","SENATE"],"sampleDescriptions":["Educate key stakeholders across the federal government on Octapharmas capabilities in support of National Security and supply chain resilience.","Educate key stakeholders across the federal government on Octapharmas capabilities in support of National Security and supply chain resilience.","Educate key stakeholders across the federal government on Octapharmas capabilities in support of National Security and supply chain resilience.","Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security.","Educated government stakeholders on Octapharmas product and manufacturing capabilities in support of National Security."]}